Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $16.90 USD
Change Today -0.04 / -0.24%
Volume 457.7K
THRX On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - theravance inc (THRX)

Name (Connections)Board RelationshipsTitleKey Developments
Paul Pepe 5 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating/Corporate Governance Committee 
Catherine Friedman 30 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 
Terrence Kearney 33 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee 

Compensation Committee* - theravance inc (THRX)

Name (Connections)Board RelationshipsTitle
Catherine Friedman 30 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Terrence Kearney 33 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating/Corporate Governance Committee
THRX Compensation vs. Industry
557.2K
443.6K
Chief Executive Officer
87.8K
293.6K
Chief Financial Officer
Share price activity for THERAVANCE INC (THRX)
52 Week Price Performance
THRX
Industry Average

Nominating Committee* - theravance inc (THRX)

Name (Connections)Board RelationshipsTitleKey Developments
William Waltrip 16 RelationshipsChairman and Chairman of Nominating/Corporate Governance CommitteeTheravance Inc. Announces Cash Dividend for the Fourth Quarter Ended September 30, 2014, Payable on December 23, 2014; Announces Executive Changes
10/30/14
Paul Pepe 5 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating/Corporate Governance CommitteeTheravance, Inc. Appoints Eric d'Esparbes as Senior Vice President and Chief Financial Officer
10/9/14
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating/Corporate Governance CommitteeTheravance Inc. Announces Management Resignations, Effective September 30, 2014
09/19/14

Corporate Governance Committee* - theravance inc (THRX)

Name (Connections)Board RelationshipsTitle
Paul Pepe 5 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
James Tyree 45 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee
William Waltrip 16 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating/Corporate Governance Committee
THRX and Competitor
Insiders vs. External
Board
17%
83%
Theravance Inc.
4%
96%
Nektar Therapeutics
15%
85%
Ironwood Pharmaceuticals, Inc.
16%
84%
Progenics Pharmaceuticals, Inc.
25%
75%
Sucampo Pharmaceuticals, Inc.
43%
57%
Synergy Health plc
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THRX:US $16.90 USD -0.04

THRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ironwood Pharmaceuticals Inc $14.11 USD +0.29
Nektar Therapeutics $11.50 USD -0.02
Progenics Pharmaceuticals Inc $5.63 USD +0.15
Sucampo Pharmaceuticals Inc $16.23 USD +0.47
Synergy Health PLC 1,823 GBp -72.00
View Industry Companies
 

Industry Analysis

THRX

Industry Average

Valuation THRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 120.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 61.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAVANCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.